October 25,2010
Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
Recent News
- Wyden Statement on New Biden-Harris Administration Affordable Housing Initiative
- Wyden Hearing Statement on Tax Court Nominations
- Wyden, Crapo Lead Introduction of Bipartisan Bill to Improve Unemployment Insurance
- Wyden Renews Call for PBM Reforms Needed to Lower Drug Prices and Increase Access Following New FTC Report
- Wyden and Whitehouse Ask Attorney General to Appoint Special Counsel to Investigate Potential Ethics and Tax Law Violations by Justice Clarence Thomas and His Benefactors